Maximus (NYSE:MMS) Updates FY 2026 Earnings Guidance

Maximus (NYSE:MMS) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 7.950-8.250 for the period, compared to the consensus estimate of 7.400. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.6 billion.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. Zacks Research cut shares of Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 27th. Weiss Ratings upgraded Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.00.

Maximus Price Performance

MMS opened at $77.89 on Thursday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. The stock has a market capitalization of $4.39 billion, a PE ratio of 14.35 and a beta of 0.57. The stock’s 50 day moving average price is $86.11 and its 200-day moving average price is $79.33. Maximus has a 52-week low of $63.77 and a 52-week high of $92.50.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be issued a $0.30 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.20 annualized dividend and a yield of 1.5%. Maximus’s dividend payout ratio (DPR) is 22.10%.

Insider Activity

In related news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total transaction of $146,284.60. Following the sale, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company’s stock.

Hedge Funds Weigh In On Maximus

Institutional investors and hedge funds have recently made changes to their positions in the business. Sivia Capital Partners LLC purchased a new position in Maximus in the second quarter worth about $204,000. Jane Street Group LLC increased its position in shares of Maximus by 941.2% during the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after acquiring an additional 88,835 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Maximus by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after acquiring an additional 221 shares in the last quarter. Finally, Royal Bank of Canada boosted its stake in Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after purchasing an additional 11,716 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.